생체자기비즈 전문제조업체

핵산추출 분야 자성비드 원료 시장조사 보고서
Market status
The global market size of nucleic acid extraction magnetic beads is expected to reach $2.044 10억 2024. 전염병 이후 수요 감소의 영향을 받았지만, it still maintains a compound annual growth rate of 5.27% driven by technological iteration. The domestic market shows a rapid growth trend, with a compound growth rate of over 25% ~에서 2020 에게 2024, and the scale is expected to exceed 20 10억 위안 2025. With the advantages of high throughput and automation, the penetration rate of magnetic bead method continues to improve in molecular diagnosis, gene sequencing and other fields.
competition pattern
The market competition pattern is dominated by international giants, with Thermo Fisher, Roche, Qiagen, and Beckman occupying the main share. Its magnetic bead raw materials (such as Thermol’s Dynabeads and Beckman’s AMPure XP) are regarded as the “금본위제” in the industry due to their stability and high compatibility.
Domestic enterprises such as Shanghai LingJun Biotech, Suzhou Beaver Biology and Jifan Biology gradually realize import substitution through technological breakthroughs; Na Micro Technology (listed in 2021) has completed the pilot test of chemiluminescent magnetic beads, and Arun Micro nano (a subsidiary of Zhijiang Biology) has mastered the international leading surface modification technology. ~ 안에 2024, the market share of domestic magnetic bead manufacturers will increase to 35%, an increase of 15 percentage points compared with 2020. Middle and downstream enterprises such as Huada Intelligent Manufacturing and Mindray Medical will also lay out self-developed magnetic beads. ~ 안에 2022, CR3 (the market share of the top three enterprises) was not disclosed, but the penetration rate of local enterprises in the middle and low-end market was significantly increased.
Material innovation and function expansion:
Magnetic bead surface modification technology: silicon hydroxyl (SiO2), 카르복실기 (-쿠오) and other functional groups are optimized to improve nucleic acid adsorption efficiency, such as metal organic polymer modified magnetic beads developed by Wu Lidong team, which has been applied in novel coronavirus detection;
High-throughput automation: the demand for magnetic bead raw materials adapted to the 96-channel extraction instrument has surged, promoting enterprises to develop products with better dispersion and faster magnetic response;
Application scenario extension: In addition to traditional pathogen detection, using magnetic beads in NGS library building, 단일 세포 시퀀싱, and exosome isolation is expanded, such as AMPure XP magnetic beads in second-generation sequencing for fragment screening.
에이pplication area
의료 진단: infectious diseases (such as COVID-19, HPV), tumor gene testing and genetic disease screening;
Scientific research and pharmaceutical production: gene editing, nucleic acid purification in drug development;
Forensic and agricultural: sample trace DNA extraction and transgene testing.
미래에, as domestic enterprises break through the technical barriers of the whole chain of “magnetic bead-reagent-equipment” and the promotion of precision medical policies, China’s magnetic bead raw material market is expected to achieve a breakthrough in localization in the high-end field, and is expected to form a multi-level competition pattern by 2030. At the supply chain level, the supply of domestic magnetic beads reached 320 million copies in 2024, covering more than 80% of nucleic acid extraction reagent manufacturers.
공급자
상하이 링쥔 생명공학 유한회사, 주식회사에 설립되었습니다 2016 생체자성재료 및 핵산추출시약 전문제조업체입니다..
핵산 추출 및 정제 분야에서 풍부한 경험을 보유하고 있습니다., 단백질 정제, 세포 분리, 화학발광, 및 기타 기술 분야.
우리의 제품은 많은 분야에서 널리 사용됩니다., 의료 테스트와 같은, 유전자 검사, 대학 연구, 유전자 육종, 등. 우리는 제품을 제공할 뿐만 아니라 OEM도 수행할 수 있습니다., ODM, 그리고 다른 필요. 관련된 필요사항이 있는 경우, 저희에게 연락하게 자유롭게 느끼십시오 .

























